Phase II study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/4/5/423/342647/4-5-423.pdf
Reference8 articles.
1. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/− MER) for metastatic carcinoma of the breast A CALGB study;Aisner;J Clin Oncol,1987
2. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy;Bull;Cancer,1978
3. Anthracyclines active via the oral route: Luxury of necessity?;Piccart;Ann Oncol,1992
4. Prednimustine in advanced breast cancer: A review;Mouridsen;Semin Oncol,1986
5. Idarubicin (4-demethoxydaunorubicin). A preliminary overview of preclinical and clinical studies;Ganzina;Invest N Drugs,1896
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine Capecitabine in Combination With Paclitaxel in Patients With Advanced Solid Malignancies;Journal of Clinical Oncology;1999-06
2. Oral doxifluridine plus levoleucovorin in elderly patients with advanced breast cancer;Cancer;1998-09-15
3. Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma;CANCER-AM CANCER SOC;1997
4. Issues concerning the role of chemotherapy and hormonal therapy of bone metastases from breast carcinoma;Cancer;1997-10-15
5. Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study;European Journal of Cancer;1997-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3